fda glp-1 compounding warning october 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns – Partnership for Safe Medicines New project announcement: HHS‑OIG is
Description
Wichita, KS.
Originally CD was considered as a malabsorption syndrome of childhood, whereas it is now recognised as a disease which may be diagnosed at any age
What this means for food R&D.
A microscopic view of the hindbrain reveals support cells (highlighted in green, red, yellow and purple) that produce appetite-suppressing molecules
Studies show up to 25-39% of weight lost on GLP-1s can come from lean mass - without intentional resistance training and adequate protein
You can read the full paper in Nature here: #Genetics #PrecisionMedicine #GLP1 #Obesity #Biotech #Semaglutide #Tirzepatide #Nature #23andMe #GWAS #ClinicalResearch | 24 comments on LinkedIn
